Infantino M, Nagy E, Bizzaro N, Fischer K, Bossuyt X, Damoiseaux J
J Transl Autoimmun. 2022; 5:100139.
PMID: 35028552
PMC: 8741517.
DOI: 10.1016/j.jtauto.2021.100139.
Fert-Bober J, Darrah E, Andrade F
Immunol Rev. 2019; 294(1):133-147.
PMID: 31876028
PMC: 8061312.
DOI: 10.1111/imr.12834.
Zhou Z, Austin G, Shaffer R, Armstrong D, Gentry M
Trends Mol Med. 2019; 25(12):1094-1109.
PMID: 31522955
PMC: 6889062.
DOI: 10.1016/j.molmed.2019.08.005.
Das T, Chen Z, Hendriks R, Kool M
Front Immunol. 2018; 9:104.
PMID: 29515565
PMC: 5826380.
DOI: 10.3389/fimmu.2018.00104.
Lenert A, Niewold T, Lenert P
Drug Des Devel Ther. 2017; 11:747-757.
PMID: 28331294
PMC: 5357079.
DOI: 10.2147/DDDT.S114552.
Establishing a reference interval for serum anti-dsDNA antibody: A large Chinese Han population-based multi-center study.
Deng C, Zhang S, Hu C, Li P, Wu Z, Chen S
PLoS One. 2017; 12(2):e0168871.
PMID: 28151970
PMC: 5289441.
DOI: 10.1371/journal.pone.0168871.
Pathogenesis of proliferative lupus nephritis from a historical and personal perspective.
Fu S, Wang H, Dai C, Sung S, Gaskin F
Clin Immunol. 2016; 185:51-58.
PMID: 27591148
PMC: 5332347.
DOI: 10.1016/j.clim.2016.07.024.
Anti-dsDNA Antibodies are one of the many autoantibodies in systemic lupus erythematosus.
Fu S, Dai C, Zhao Z, Gaskin F
F1000Res. 2015; 4(F1000 Faculty Rev):939.
PMID: 26594353
PMC: 4648223.
DOI: 10.12688/f1000research.6875.1.
Immunoglobulin light chain allelic inclusion in systemic lupus erythematosus.
Fraser L, Zhao Y, Lutalo P, DCruz D, Cason J, Silva J
Eur J Immunol. 2015; 45(8):2409-19.
PMID: 26036683
PMC: 5102633.
DOI: 10.1002/eji.201545599.
Protein microarrays: a new tool for the study of autoantibodies in immunodeficiency.
Rosenberg J, Utz P
Front Immunol. 2015; 6:138.
PMID: 25904912
PMC: 4387933.
DOI: 10.3389/fimmu.2015.00138.
Associations between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: analysis of a regional Swedish register.
Frodlund M, Dahlstrom O, Kastbom A, Skogh T, Sjowall C
BMJ Open. 2013; 3(10):e003608.
PMID: 24163206
PMC: 3808756.
DOI: 10.1136/bmjopen-2013-003608.
Neutrophil extracellular chromatin traps connect innate immune response to autoimmunity.
Radic M, Marion T
Semin Immunopathol. 2013; 35(4):465-80.
PMID: 23595413
DOI: 10.1007/s00281-013-0376-6.
Pathology and Pathogenesis of the Diffuse Collagen Diseases : Part III.
Movat H
Can Med Assoc J. 2010; 83(15):797-803.
PMID: 20326480
PMC: 1938437.
Targeted therapies in rheumatoid arthritis: Focus on rituximab.
Teng Y, Huizinga T, van Laar J
Biologics. 2009; 1(4):325-33.
PMID: 19707303
PMC: 2721296.
Autoantigens in systemic autoimmunity: critical partner in pathogenesis.
Rosen A, Casciola-Rosen L
J Intern Med. 2009; 265(6):625-31.
PMID: 19493056
PMC: 3665289.
DOI: 10.1111/j.1365-2796.2009.02102.x.
ICOS controls effector function but not trafficking receptor expression of kidney-infiltrating effector T cells in murine lupus.
Odegard J, DiPlacido L, Greenwald L, Kashgarian M, Kono D, Dong C
J Immunol. 2009; 182(7):4076-84.
PMID: 19299705
PMC: 2746004.
DOI: 10.4049/jimmunol.0800758.
Defective B cell tolerance checkpoints in systemic lupus erythematosus.
Yurasov S, Wardemann H, Hammersen J, Tsuiji M, Meffre E, Pascual V
J Exp Med. 2005; 201(5):703-11.
PMID: 15738055
PMC: 2212839.
DOI: 10.1084/jem.20042251.
Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis.
Waters S, McDuffie M, Bagavant H, Deshmukh U, Gaskin F, Jiang C
J Exp Med. 2004; 199(2):255-64.
PMID: 14718514
PMC: 2211766.
DOI: 10.1084/jem.20031519.
Autoimmune disorders: a concept of treatment based on mechanisms of disease.
Miescher P, Zavota L, Ossandon A, Lagana B
Springer Semin Immunopathol. 2003; 25 Suppl 1:S5-S60.
PMID: 14655023
DOI: 10.1007/s00281-003-0151-1.
Anti-nuclear factors and serum complement in systemic lupus erythematosus.
Morse J, MULLER-EBERHARD H, KUNKEL H
Bull N Y Acad Med. 1962; 38:641-51.
PMID: 14476340
PMC: 1804852.
